Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lotilaner for Mosquitocidal Activity in Healthy Participants in Mali
NCT07758985Phase 1Recruiting
- Sponsor
- Medicines for Malaria Venture
- Start
- Sep 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lotilaner in malaria (6 arms), sponsored by Medicines for Malaria Venture. Primary endpoint: Safety and tolerability of Lotilaner. Started Sep 2026; status: recruiting.
02
Drugs
lotilaner
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07758985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07758985.